(Q44513039)

English

Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

pharmacotherapy

0 references

author name string

Salvatore Sapienza

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Patricia Sacco

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kristine Floyd

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Joseph DiCesare

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

QuynhChau Diem Doan

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1872-1887

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics of patients with uncontrolled hypertension in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of treating hypertension in elderly people--an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The rationale for combination versus single-entity therapy in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study e

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Physician-related barriers to the effective management of uncontrolled hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980174-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80174-1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44513039&oldid=2026567414"